Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical Care

Bingham, Kathleen; Rozenbojm, Nathalie; Chong-East, Mariah; Touma, Zahi

doi:10.1002/acr2.11205

Cited by 6 publications

(4 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Consistent with prior studies, anxiety, depression, and adjustment disorders were more common before the onset of the pandemic among patients with SARD in this sample 5,15,30 . As patients with SARD went into the pandemic with a high prevalence of stress‐related disorders, they may have fared worse than the general population during the pandemic 31 . In models adjusting for prior mental health status vs. without, as well as in models adjusting for antidepressant/anxiolytic medication use vs. without, we saw no significant differences in PTSD symptomology between SARD and non‐SARD patients.…”

Section: Discussionsupporting

confidence: 86%

“…5,15,30 As patients with SARD went into the pandemic with a high prevalence of stress-related disorders, they may have fared worse than the general population during the pandemic. 31 In models adjusting for prior mental health status vs. without, as well as in models adjusting for antidepressant/anxiolytic medication use vs. without, we saw no significant differences in PTSD symptomology between SARD and non-SARD patients. Although we did find that patients with SARD had a higher prevalence of anxiety, depression, or adjustment disorders, our findings do not suggest that this conferred a higher risk for PTSD symptoms in the context of the pandemic.…”

Section: Discussionmentioning

confidence: 65%

See 1 more Smart Citation

Posttraumatic stress disorder symptoms in systemic autoimmune rheumatic disease patients during the early COVID‐19 pandemic

Oakes,

Ellrodt,

Yee

et al. 2023

Int J of Rheum Dis

View full text Add to dashboard Cite

AimGiven reports of increased prevalence of PTSD symptoms at COVID‐19 pandemic onset, we aimed to assess the prevalence of posttraumatic stress disorder (PTSD) symptoms at pandemic onset in individuals with and without systemic autoimmune rheumatic disease (SARD).MethodsIn May 2020, we invited 6678 patients to complete the Brief Trauma Questionnaire and the Posttraumatic Stress Disorder Checklist (PCL‐5), validated PTSD symptom screenings. We compared responses from patients with and without SARD using multivariable logistic regression.ResultsWe received 1473 responses (22% response rate) from 5/2020 to 9/2021 (63 with prior PTSD diagnoses, 138 with SARD history). The SARD population was more female (p .0001) and had a higher baseline prevalence of stress disorders (56% vs. 43%, p .004). SARD subjects reported more experiences with life‐threatening illness, 60%, versus 53% among those without SARD (p .13), and more antidepressant or anxiolytic medication use pre‐pandemic (78% vs. 59%, p .0001). Adjusting for pre‐pandemic PTSD diagnosis, younger age and history of stress disorder were the most significant predictors of PCL‐5 positivity. There were no significant differences in PCL‐5 score or positivity among those with or without SARD.ConclusionIn this population, patients with SARD had a higher pre‐COVID‐19 prevalence of stress‐related conditions, but it was not the case that they had an increased risk of PTSD symptoms in the early pandemic. Younger individuals, those with baseline depression, anxiety, or adjustment disorders, and those taking antidepressant or anxiolytic medications were more likely to have PTSD symptoms in the first waves of the COVID‐19 pandemic.

show abstract

Section: Discussionsupporting

confidence: 86%

Section: Discussionmentioning

confidence: 65%

Posttraumatic stress disorder symptoms in systemic autoimmune rheumatic disease patients during the early COVID‐19 pandemic

Oakes,

Ellrodt,

Yee

et al. 2023

Int J of Rheum Dis

View full text Add to dashboard Cite

show abstract

“…The results stated several potential contributing factors to psychological distress in the given situation including fear of infection, uncertainty related to medication, access to usual care and effect of social isolation. No therapeutic impact on reducing the level of psychological distress among SLE patients in the control group 13,14 . Limitations: Long term follow up could not be completed.…”

Section: Discussionmentioning

confidence: 97%

Efficacy of Acceptance and Commitment Therapy for Psychological Distress in Patients with Systemic Lupus Erythematous

Akhtar¹,

Majeed²

2022

PJMHS

View full text Add to dashboard Cite

Background: Prolonged physical illnesses and resultant health conditions may give rise to mental health problems and psychological distress. Aim: To see the efficacy of Acceptance and Commitment Therapy (ACT) for patients suffering from Systemic Lupus Erythematous. Study Design: Randomized Control Trials. Methodology: A purposive sample of forty adult patients with a mean age of 29.25 years (SD= 6.37) suffering from SLE were enrolled for the research after their signed written informed consent. The sample was drawn from two public hospitals with the prior permission of authorities. Randomized Control Trials were carried out on forty patients with SLE after the random assignment to the experimental group and control group. Pre and post-treatment assessment was completed with the help of a demographic questionnaire, medical history Performa and psychological distress scale. Results: Equal number of men and women were included in the present research. Most of the participants' education level was matric and they belong to middle socioeconomic status. results indicated that ACT significantly contributed to the reduction of psychological distress among the patients of the experimental group p<0.01 i.e. 0.00, (M=19.85, SD=2.27); suggesting a decrease in the level of psychological distress with a large effect size whereas no significant difference in pre and post-test scores of control group p>0.05 i.e. 0.66, was observed. Conclusion: It was concluded that ACT proved an efficacious mode of treatment for psychological distress in patients with SLE. Keywords: Acceptance and Commitment Therapy, psychological Distress and SLE.

show abstract

“…Despite known benefits of PA in RMD management, patients with RMDs often do not engage in adequate PA ( 14 ), reporting barriers such as limited time, motivation, and support for and access to PA opportunities as well as disease‐specific barriers (eg, fatigue, pain, fear of exacerbating disease) ( 15 , 16 , 17 ). Patients with RMDs also experienced unique additional stressors due to the COVID‐19 pandemic, including barriers to medication access and concern for increased risk of infection ( 18 , 19 , 20 , 21 ). In the spring of 2020, actions were taken to mitigate the spread of COVID‐19 in the United States, including the closure of nonessential businesses, indoor exercise facilities, and other recreational areas ( 22 ).…”

Section: Introductionmentioning

confidence: 99%

Perceived Impact of the COVID‐19 Pandemic on Physical Activity Among Adult Patients With Rheumatologic Disease

Saxena‐Beem

Dickson

Englund

et al. 2022

ACR Open Rheumatology

View full text Add to dashboard Cite

Objective The objective of this cross‐sectional study was to investigate the impact of the COVID‐19 pandemic on physical activity (PA) levels of patients with rheumatic and musculoskeletal diseases (RMDs) and to examine factors associated with decreased PA. Methods A sample of adult patients with RMDs (n = 7,776) was identified through electronic medical records from an academic health care system in North Carolina. Invitations to participate in an online survey were sent between July 2020 and September 2020 to assess self‐reported changes in PA during the COVID‐19 pandemic. Descriptive statistics, age‐adjusted prevalence odds ratios (PORs), and 95% confidence intervals (CIs) were computed to examine patient characteristics associated with decreased PA. Results A total of 893 eligible participants completed the survey (mean age 57.8 ± 14.9 years, 75.8% female). The most common primary diagnoses reported among participants included rheumatoid arthritis (27.3%), osteoarthritis (16.0%), and systemic lupus erythematosus (SLE) (13.0%). More than half of participants (56.8%) reported engaging in less PA since the pandemic began. Factors associated with engaging in less PA included lower self‐reported general health (POR, 2.21; CI, 1.64‐2.97) and a diagnosis of SLE (POR, 1.57; CI, 1.03‐2.38). Comorbidities associated with decreased PA included chronic pain (POR, 1.38; CI, 1.04‐1.82), depression (POR, 1.48; CI, 1.09‐2.01), and hypertension (POR, 1.44; CI, 1.10‐1.90). Conclusion The COVID‐19 pandemic has exacerbated barriers to PA in patients with RMDs. There is a critical need to provide resources, support, and multifaceted programs to encourage PA in patients with RMDs during the COVID‐19 pandemic.

show abstract

Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical Care

Cited by 6 publications

References 52 publications

Posttraumatic stress disorder symptoms in systemic autoimmune rheumatic disease patients during the early COVID‐19 pandemic

Posttraumatic stress disorder symptoms in systemic autoimmune rheumatic disease patients during the early COVID‐19 pandemic

Efficacy of Acceptance and Commitment Therapy for Psychological Distress in Patients with Systemic Lupus Erythematous

Perceived Impact of the COVID‐19 Pandemic on Physical Activity Among Adult Patients With Rheumatologic Disease

Contact Info

Product

Resources

About